First Possible HIV Cure Reported in Canada After Bone Marrow Transplant
Michael Gwarisa Canada has recorded its first possible HIV cure in a 62-year-old man who has remained in sustained remission following a bone marrow transplant, according to a report from the University of Toronto. The case, known as the “Toronto patient,” was developed through a collaboration between clinicians and researchers at University Health Network, Unity
Read More
Merck Once-Daily ARV Pill Could Reach Market Soon
Michael Gwarisa In a move that could significantly reduce pill burden and improve adherence to antiretroviral therapy (ART), the United States Food and Drug Administration has approved a new once-daily pill developed by Merck & Co. for adults living with HIV-1 who are already virologically suppressed. The pill is intended to replace a patient’s existing
Read More
Low Viral Load Doesn’t Mean Zero Risk: What New Uganda Study Means for U=U
Michael Gwarisa For years, the global HIV response has rallied around a simple but powerful message: Undetectable equals Untransmittable, widely known as U=U. Backed by strong scientific evidence, the concept has transformed both HIV prevention and the lives of people living with the virus. But new findings from the Rakai HIV Cohort Study in Uganda
Read More
Monthly HIV Injectable Offers Hope for Patients Struggling with Adherence
Michael Gwarisa A monthly injectable HIV treatment combining long-acting cabotegravir and rilpivirine has been shown to outperform standard daily oral antiretroviral therapy (ART) among people who struggle to stick to treatment, according to findings from a major randomized clinical trial. The study, published in February 2026 in the New England Journal of Medicine, provides strong
Read More
New Single-Pill HIV Treatments Show Strong Results in Global Trials
Michael Gwarisa Two new once-daily HIV treatments taken as a single pill have shown strong results in late-stage clinical trials, raising hopes for simpler treatment options for people living with the virus. The studies were presented at the Conference on Retroviruses and Opportunistic Infections 2026 in Denver, United States. Researchers tested whether the new drugs
Read More
Zimbabwe Launches Revolutionary HIV Prevention Program with Lenacapavir
Watch: Zimbabwe Launches Lenacapavir: New HIV Prevention Injection With 99.9% Protection Michael Gwarisa In a major step forward for HIV prevention, Zimbabwe has officially launched the rollout of Lenacapavir, a long-acting injectable drug that provides new protection options for communities at high risk of HIV infection. Zimbabwe joins South Africa, Kenya, Zambia, and Eswatini among
Read MoreCritical Gaps in Vital Monitoring Threaten Care Outcomes In Those Ageing With HIV In Zimbabwe
By Michael Gwarisa For 21 years, Martha Tholanah (60) has lived with HIV. She has experienced it all, from the days when an HIV diagnosis was a death sentence to today, when people living with HIV can lead healthy, fulfilling lives. Testing positive on January 3, 2003, Martha recalls her heartbreak when health workers informed
Read MoreMeet Dr. Dhodho: The Once Sickly Village Boy Who Transformed Rural Zimbabwe’s HIV Response
By Michael Gwarisa He wears many hats. Dr. Efison Dhodho is currently the Knowledge Manager for the Zimbabwe College of Public Health Physicians, a dedicated researcher, and the Director for Strategic Information, Evaluation, Learning, and Information Technology Systems at the Organization for Public Health Interventions and Development (OPHID). Born into a family of 13 as
Read More
What’s next for Zimbabwe’s collapsing health system?
Health systems are, at their core, meant to promote, restore or maintain health. Their objective is to improve the length and quality of citizens’ life from the cradle to the grave. Health is therefore a fundamental human right. This was very clear to the different healthcare delivery administrators and practitioners in Zimbabwe for the last
Read More
150 000 New HIV infections Recorded Among Children In 2020
THE Joint United Nations Programme on HIV and AIDS (UNAIDS) says most of the 150 000 new HIV infections recorded among children in 2020 could have been prevented if interventions targeting the most affected groups had been implemented. HealthTimes Reporter According to the UNAIDS weekly update, a strong start would be to better engage women
Read More